Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis

Despite the use of various pharmacotherapeutic strategies, fibrosis due to nonalcoholic steatohepatitis (NASH) remains an unsatisfied clinical issue. We investigated the effect of sevelamer, a hydrophilic bile acid sequestrant, on hepatic fibrosis in a murine NASH model. Male C57BL/6J mice were fed...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Microorganisms
Huvudupphovsmän: Tsuji, Yuki, Kaji, Kosuke, Kitade, Mitsuteru, Kaya, Daisuke, Kitagawa, Koh, Ozutsumi, Takahiro, Fujinaga, Yukihisa, Takaya, Hiroaki, Kawaratani, Hideto, Namisaki, Tadashi, Moriya, Kei, Akahane, Takemi, Yoshiji, Hitoshi
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7357162/
https://ncbi.nlm.nih.gov/pubmed/32575352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/microorganisms8060925
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk